Early PET scan to check how well chemotherapy works in metastatic colorectal cancer
Part of Cancer, Digestive system clinical trials.
This trial uses a special PET scan called 18F-FDG to see how well your first chemotherapy is working, just a couple of weeks after you start. The goal is to find out early whether the treatment is helping, so you and your doctor can decide together if you should continue or switch to a different approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have colorectal cancer that has spread to other parts of the body (like liver, lungs, or belly lining).
- The spread (metastases) must be measurable and potentially removable with surgery.
- You must be planning to start your first chemotherapy (possibly with a targeted therapy) as your initial treatment for the advanced disease.
- You need to be in fairly good general health (able to care for yourself).
- If you had chemotherapy after surgery in the past, it must have stopped more than 6 months before your cancer returned.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special PET scan (FAPI) to detect a specific, more aggressive type of colorectal cancer (CMS4) in people who have liver tumors that can be surgically removed. The goal is to see if the scan can help doctors choose the best treatment for you.
This trial uses two types of PET/CT scans (FDG and FAPI) to better see and track colorectal cancer that has spread to the belly lining (peritoneum). It aims to help doctors choose the best treatment by improving how they detect and monitor the cancer.
This trial tests whether a special PET scan (FDG PET-CT) can better track how well treatment is working for people with advanced breast cancer. It may help doctors choose the best therapy and monitor response over time.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
This trial tests a new type of PET scan (FAPI-PET) to see if it can better find colon cancer that has spread to lymph nodes or other parts of the body. It may help doctors plan the right treatment for you.
Hear when a new Metastatic Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.